Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REPEAT: MARKET COMMENT: UK Stocks Close Lower After Roller Coaster Day

Thu, 07th Nov 2013 17:45

LONDON (Alliance News) - UK stocks closed lower Thursday following a volatile day of trading as investors reacted to a surprise rate cut by the European Central Bank and data from both the UK and US.

London's major indices opened flat to slightly lower Thursday as traders showed caution ahead of a series of much-anticipated data releases and central bank announcements.

With the Bank of England maintaining its record-low 0.50% interest rate and the size of its quantitative easing at GBP375 billion, in line with expectations, the first major release of the day did little to stir the markets.

The ECB's surprise 25-basis-point rate cut, however, sparked an stockmarket rally, as investors reveled in the prospect of even cheaper lending. UK and European stocks jumped on the news that the central bank was trimming its benchmark refinancing rate to a record low of 0.25% amid a slackening in inflation and sluggish economic growth in the eurozone.

"The combination both of October's unexpectedly large fall in inflation, the strength of the euro exchange rate, and growing concerns over liquidity conditions in the banking sector appears to have persuaded most members that some sort of reaction was necessary," said Jonathan Loynes, chief economist with the Capital Economics research group.

In the press conference in the immediate aftermath of the cut, ECB President Mario Draghi warned that, while "we may experience a prolonged period of low inflation," there was no threat of deflation in the currency bloc, rejecting any comparison with Japan, which has suffered from 15 years of deflation. Draghi declined to give a clear indication if or when the Central Bank will use quantitative easing, or asset purchases, as other central banks have, as a tool to spur demand, but did indicate that a further rate cut, presumably to zero, remains an available tool.

The equities rally was short-lived, however, as concerns about the outlook for the US Federal Reserve's USD85 billion-per-month stimulus programme helped to limit the upside for the markets. A Commerce Department report showed stronger-than-expected US third-quarter GDP growth, rasing the market concerns.

Spreadex's David White commented that "global markets whipsawed today in light of an unexpected rate cut by the ECB and then against a firm Q3 GDP figure from the States.

What began as a reason to bid equities was soon overtaken by a stronger one to sell," White said.

The report revealed that US gross domestic product rose by 2.8% in the third-quarter, compared to economist estimates for an increase of 2.0%. GDP growth accelerated from the 2.5% increase recorded in the second quarter, reflecting a deceleration in imports and acceleration in private inventory investment and in state and local government spending.

"Signs that the US economy slowed through the end of the third-quarter of 2013 have been washed away in one fell swoop, with the GDP report easily crushing expectations. In fact, only two economists of 87 polled suggested that the economy would grow by plus 2.8% or more," said Christopher Vecchio, currency analyst at DailyFX.

Added Paul Ashworth, Chief US Economist at Capital Economics, said, "overall, the pick-up in GDP growth will presumably add to the speculation that the Fed might yet begin tapering its asset purchases in December, even though the ECB is loosening monetary policy in the euro-zone."

"Frankly, it's hard to know exactly what precise improvement Fed officials are looking for after all the flip-flopping," Ashworth added. "October's payrolls figures, due out tomorrow, will provide a little more insight."

A separate report from the US Labor Department showed that initial jobless claims fell for the fourth straight week, coming in roughly in line with economist estimates. Initial jobless claims fell to 336,000 in the week ended November 2, a decrease of 9,000 from the previous week's revised figure of 345,000. Economists had expected claims to dip to 335,000 from the 340,000 originally reported for the previous week.

The FTSE 100 eventually closed down for a third consecutive day, falling 0.7% to close at 6,697.22. The FTSE 250 closed off 0.1% at 15,389.52, while the AIM All-Share index ended down 0.2% at 813.71.

Negative sentiment was shared in the US. At the London close, the DJIA was down 0.4% at 15,682.21, the S&P was down 0.7% at 1,757.87, and the Nasdaq was down 1.3% at 3,879.85.

Twitter was soaring. Shares in the social-media darling were trading above USD50.00 on their first day of trading, an increase of more than 90% from its offer price. The soaring debut on the New York Stock Exchange came just hours after Twitter said it was pricing its initial public offering at USD26.00 dollars a share, the third time it raised its IPO price since filing to go public.

In the UK, general retailers was among the biggest gaining FTSE 350 sector indices, up 0.5%, after Halfords, up 13% at 471.9968 pence, closed the day as the biggest gainer on the FTSE 250. The company reported higher sales and profits for the first half of its financial year, as the UK's growing passion for cycling and a revamp of its profits drove growth. The company said the good summer weather had driven up sales of cycles, while its recent revamp meant it had the stock and better products to meet the demand. Halfords reported a pretax profit of GBP44.6 million in the six months to September 27, up from GBP42.4 million a year earlier, and well ahead of a consensus forecast of GBP38.3 million. Revenues rose to GBP490.6 million, from GBP455.6 million.

Grainger, closing up 4.6% at 206.10p, was another big winner in the FTSE 250. The company revealed that it had swung to a profit for the full-year, as it positioned itself to take advantage of the UK housing recovery. Grainger said the UK government's efforts to help Britons buy homes through mortgaging financing schemes, as well as to boost development of the rental sector through the Build-to-Rent fund, were helping to strengthen the market. The company posted pretax profit of GBP64.3 million for the period ended September 30, compared with a GBP1.7 million loss a year earlier. The profit rise came as a result of efforts to reduce its debt, it said, which declined to GBP959 million from GBP1.19 billion a year earlier.

FTSE 250-listed Inmarsat closed down 4.9% at 678.8998p. It was the biggest loser on the mid-cap index. The satellite operator posted declining revenues in the third quarter. It said that several of its businesses were hurt by reduced military activity in Afghanistan, and that the launch of its Global Xpress satellite was delayed. The company posted total revenues of USD306.9 million, down from USD325.9 million in the previous year. Inmarsat also warned that in 2014, operating cost investments in the military radio spectrum band, L-Band, will coincide with a difficult outlook for its US government business. These factors are expected to combine to apply pressure on operating profits during 2014.

In the FTSE 100, Randgold Resources closed up 7.1% at 4,931.2p as the biggest gainer. The gold exploration and mining company revealed that its third-quarter sales and production had increased. While pretax profit fell 3.8% to USD126.6 million for the three months ended September 30, from USD131.6 million in the third-quarter 2012, it more than doubled its second-quarter figure of USD60.7 million.

After the market close, Royal Bank of Scotland said it had agreed to pay USD153.7 million to settle a US Securities and Exchange Commission probe into a USD2.2 billion residential mortgage-backed security the bank issued in 2007. The bank had already set aside a provision to cover the settlement. It had neither admitted nor denied the SEC allegations that its prospectus statement on the offering was misleading. RBS shares had closed down 0.9% at 324.95 pence prior to announcement.

In the forex market, the euro was hit hard Thursday. After slumping in the immediate aftermath of the ECB's rate cut decision, the strong US GDP figures sent the currency even lower. At the close of the UK equity trading, the euro was quoted at USD1.3390, having slipped to USD1.3294, its lowest point since September 16, in earlier trading.

The euro also was trading at GBP0.8333, having fallen to 0.8297, a low since mid-January, earlier in the day.

In the data calendar Friday, the Chinese trade balance is released overnight at 0200 GMT, ahead of German and French trade balances at 0700 GMT and 0745 GMT, respectively. UK goods and total trade balance numbers are scheduled for 0930 GMT.

In the US, October the much-anticipated nonfarm payrolls and unemployment rate figures are due to be released at 1330 GMT. US personal income, consumption, and spending data is expected at 1330 GMT.

Blue-chip Rolls-Royce is joined by FTSE 250-listed Hikma Pharmaceuticals, Bovis Homes and Tullett Prebon, amongst others, in releasing interim management statements Friday. Rentokil Initial provides a trading statement.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more
20 Apr 2022 07:39

Hikma gets preliminary approval from US FTC for Custopharm deal

(Sharecast News) - Hikma Pharmaceuticals has received preliminary approval from the US Federal Trade Commission for the acquisition of sterile injectables company Custopharm Inc from Water Street Healthcare for up to $425m.

Read more
12 Apr 2022 10:11

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
10 Mar 2022 16:10

UK dividends calendar - next 7 days

Friday 11 March  
Avon Protection PLCdividend payment date
Civitas Social Housing PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Virgin Money UK PLCdividend payment date
Monday 14 March  
Tritax EuroBox PLCdividend payment date
Tuesday 15 March 
Hipgnosis Songs Fund Ltddividend payment date
Invesco Perpetual UK Smaller Cos Investment Trust PLCdividend payment date
Merchants Trust PLCdividend payment date
Wednesday 16 March  
no events scheduled 
Thursday 17 March  
Anglo American PLCex-dividend date
Anglo American PLCspecial ex-dividend date
Bellevue Healthcare Trust PLCex-dividend date
Blackrock Income & Growth Investment Trust PLCdividend payment date
BlacKRock World Mining Trust PLCex-dividend date
Brooks Macdonald Group PLCex-dividend date
Crest Nicholson Holdings PLCex-dividend date
Dunelm Group PLCex-dividend date
FW Thorpe PLCex-dividend date
FW Thorpe PLCspecial ex-dividend date
Gore Street Energy Storage Fund PLCex-dividend date
HgCapital Trust PLCex-dividend date
Hikma Pharmaceuticals PLCex-dividend date
Ideagen PLCdividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend date
Knights Group Holdings PLCdividend payment date
M&G PLCex-dividend date
Murray Income Trust PLCdividend payment date
NatWest Group PLCex-dividend date
RM PLCex-dividend date
Segro PLCex-dividend date
Spirent Communications PLCex-dividend date
Standard Life Private Equity Trust PLCex-dividend date
Treatt PLCdividend payment date
Trifast PLCex-dividend date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Mar 2022 10:02

LONDON BROKER RATINGS: Downgrades for Hikma Pharma and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
3 Mar 2022 08:28

LONDON BRIEFING: LSEG says Refinitiv savings bigger, ahead of schedule

(Alliance News) - London Stock Exchange Group on Thursday said 2021 was a successful year following the acquisition of Refinitiv, leaving the stock exchange operator well positioned as a financial market infrastructure and data business.

Read more
2 Mar 2022 09:52

LONDON BROKER RATINGS: Downgrades for AB Foods, BT and Royal Mail

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 Feb 2022 09:40

IN BRIEF: Hikma Pharmaceuticals launches first phase of share buyback

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Instructs Citigroup Global Markets Ltd, part of Citigroup Inc, to conduct the USD150 million first tranche of the USD300 million share buyback that it announced on Thursday. The initial phase will begin on Friday and end by June 25. Hikma had announced the buyback programme with its annual results, saying it reflected its strong cash generation, balance sheet strength, and confidence in future growth prospects. Hikma also had declared a final dividend of 36 cents, a 5.9% boost from a shareholder payout of 34 cents the year before. Its full-year dividend amounted to 54 US cents, up 8.0% from 50 cents.

Read more
25 Feb 2022 08:22

LONDON BRIEFING: IAG expects to fly 85% of pre-virus capacity in 2022

(Alliance News) - International Consolidated Airlines Group on Friday posted a narrowed loss for 2021, saying that after the setback caused by Omicron at the end of the year, bookings have rebounded strongly and it expects to fly 85% of its 2019 capacity in 2022.

Read more
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.